Visura Technologies

Visura Technologies is a private, commercial-stage medical device company based in San Francisco, founded in 2018. The company has successfully developed and gained FDA clearance for TEECAD, a novel disposable camera system designed to enhance the safety and efficiency of TEE probe placement, a common but blind procedure in cardiology and critical care. By providing direct visualization, Visura aims to reduce complications associated with esophageal intubation, such as trauma and perforation. The company is positioned in the high-growth intersection of the diagnostics and digital health sectors, with a clear path to market through its first commercial product.

Proprietary disposable camera system that attaches to standard TEE probes to provide real-time visualization during esophageal intubation.

Visura's TEECAD appears to be a first-in-class product with no direct, FDA-cleared competitors offering disposable visualization for TEE intubation. Indirect competition comes from the entrenched standard of practice (blind insertion) and from general video laryngoscopes used for airway management, which are not designed for TEE probe guidance. The threat of future competitive entries from large cardiology device makers (e.g., Philips, GE HealthCare, Siemens) is significant.